Re: external validation of the rotterdam prostate cancer risk calculator and comparison with stockholm3 for prostate cancer diagnosis in a Swedish population-based screening cohort
Affiliation
The Christie NHS Trust, Manchester, UK; University of Manchester, Manchester, UK.Issue Date
2024
Metadata
Show full item recordCitation
Fankhauser CD, Wettstein MS, Würnschimmel C, van Smeden M, Clarke NW. Re: External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort. Eur Urol. 2024 May 15. PubMed PMID: 38755049. Epub 2024/05/17. eng.Journal
European UrologyDOI
10.1016/j.eururo.2024.05.002PubMed ID
38755049Additional Links
https://dx.doi.org/10.1016/j.eururo.2024.05.002Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2024.05.002
Scopus Count
Collections
Related articles
- External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort.
- Authors: Palsdottir T, Grönberg H, Hilmisson A, Eklund M, Nordström T, Vigneswaran HT
- Issue date: 2023 May
- Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
- Authors: Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H, STHLM3 study group
- Issue date: 2021 Sep
- Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
- Authors: Björnebo L, Discacciati A, Falagario U, Vigneswaran HT, Jäderling F, Grönberg H, Eklund M, Nordström T, Lantz A
- Issue date: 2024 Apr 1
- Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma.
- Authors: Thompson IM, Ankerst DP, Tangen CM
- Issue date: 2010 Sep 8
- Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer Centres.
- Authors: Saarimäki L, Hugosson J, Tammela TL, Carlsson S, Talala K, Auvinen A
- Issue date: 2019 Mar